Dr. Peter Robins Watson, MD
- Medicare services, 2024
- 146
- Medicare patients, 2024
- 51
- Part D claims, 2024
- 108
- Publications
- 3
- Clinical trials
- 10
- Practice address
- 2100 Stantonsburg Rd, Greenville, NC 27834
- Practice phone
- Call (252) 847-4100
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Watson's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Peter Robins Watson is a medical oncologist in Greenville, North Carolina
Dr. Watson practices at ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina.
Dr. Watson's NPI, 1376528687, was assigned on December 8, 2005. Dr. Watson graduated from University of North Carolina at Chapel Hill School of Medicine in 1983. Dr. Watson holds North Carolina license 28446.
- NPI
- 1376528687NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1355422395
- NPI enumeration date
- December 8, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (252) 847-4100
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 69
- Medical school graduation
- 1983
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Peter Robins Watson practices at ECU Health Medical Center in Greenville, North Carolina
Dr. Watson's primary practice is ECU Health Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.
- ECU Health Medical Center2100 Stantonsburg Rd, Greenville, NC 27834 · Pitt CountyPhone(252) 847-4100
Source: Dmand AI Affiliation Data
Dr. Peter Robins Watson is affiliated with 3 sites of care and 4 medical groups
Dr. Watson's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. The medical group on file is ECU Health. Dmand AI also links Dr. Watson to 3 more medical groups and 2 group practices and clinics, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Peter Robins Watson's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Watson practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| ECU Health Medical Center | Available with a free account |
| +2 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University Health Systems of Eastern Carolina and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Peter Robins Watson is one of 203 medical oncologists in North Carolina
Medical oncology is Dr. Watson's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Watson is licensed in North Carolina.
Specialties and state licenses
- Medical oncology, North CarolinaPrimary
Medical oncologists near Dr. Watson
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Peter Robins Watson billed Medicare for 146 services in 2024
CMS data shows 146 Medicare services from Dr. Watson across 6 procedure codes in 2024, for 51 Medicare patients. Medicare paid $6,031 for them. Every service was in an office.
Dr. Watson's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Lab and pathology
- 2023: 2,4552024: 6297%
- Other services
- 2023: 5682024: 3594%
- Office and hospital visits
- 2023: 8482024: 2797%
- Surgery
- 2023: 1742024: 2287%
- Drugs given in the office
- 2023: 36,7222024: 0100%
- Imaging
- 2023: 922024: 0100%
- Tests and treatments
- 2023: 1,2222024: 0100%
Dr. Watson compared with the North Carolina median for medical oncologists, 2024
- Dr. Watson
- North Carolina median
- Medicare services
- 146vs 52572% below
- Medicare patients
- 51vs 16669% below
- Part D claims
- 35vs 36790% below
Medians across 199 medical oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Watson's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Watson?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Watson and other medical oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Peter Robins Watson treated 51 Medicare patients in 2024, average age 76
CMS counts 51 Medicare patients who saw Dr. Watson in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Watson's median patient age at 74, with 58% women.
Dr. Watson's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Watson's Medicare patients by sex, 2024
- Women2243%
- Men2957%
Chronic conditions among Dr. Watson's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer67%
- Ischemic heart disease65%
- Arthritis47%
- COPD39%
- Diabetes39%
- Heart failure33%
Share of Medicare patients with each condition. A patient can have several.
Dr. Watson's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women58%
- Men42%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Peter Robins Watson wrote 108 Medicare Part D claims in 2024
In 2024, Dr. Watson wrote 108 Medicare Part D claims for 37 patients. 81% of them were for generic drugs. CMS names the drug for 35 of them, across 3 drugs with 11 or more claims each, at $8,068 in total drug cost. In 2023, CMS named 560 claims across 22 drugs.
Dr. Watson's Part D claims by kind of drug, 2024
- Generic88 claims81%
- Brand-name20 claims19%
Dr. Watson's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5602024: 3594%
Drugs named by CMS: 3 in 2024, 22 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Peter Robins Watson scored 97 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Watson for performance year 2024, reported through an alternative payment model (APM). Dr. Watson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Watson's MIPS scores, performance year 2024
- 97of 100Final score
- 82.4of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Peter Robins Watson has 3 publications on record
Dmand AI links 3 papers to Dr. Watson, published from 2015 to 2020. Dr. Watson's most frequent co-authors are James Norman Atkins, MD, Monica Marie Bertagnolli, MD and Philip J. Bierman, MD.
Dr. Watson's papers by year, 2015 to 2020
Dr. Watson's most frequent co-authors
- James Norman Atkins, MD1 shared paper
- Monica Marie Bertagnolli, MD1 shared paper
- Philip J. Bierman, MD1 shared paper
Recent publications by Dr. Watson
See who Dr. Watson researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Watson works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Peter Robins Watson has worked on 10 clinical trials
Dmand AI links Dr. Watson to 10 clinical trials, 5 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Breast Carcinoma In Situ. National Cancer Institute (NCI) sponsors the most, 8.
Clinical trials with Dr. Watson by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 3Phase 2: 3 trials
- 1Phase 2/3: 1 trial
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Watson's trials
- Melanoma
- Nevi and Melanomas
- Breast Carcinoma In Situ
- Breast Neoplasms
- Burkitt Lymphoma
Investigators on the most trials with Dr. Watson
- Warren Lewis Robinson, FACP, MD7 shared trials
- Terrence P. Cescon, MD6 shared trials
- Mehmet Sitki Copur, MD6 shared trials
Recent clinical trials with Dr. Watson
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer (opens in a new tab)
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (opens in a new tab)
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Peter Robins Watson received $7,208 in industry payments from 2016 to 2025
CMS Open Payments shows 516 general payments to Dr. Watson from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Genentech, Inc. paid the most, $787.
General payments to Dr. Watson by program year, 2016 to 2025
General payments to Dr. Watson by kind, 2016 to 2025
- Food and beverage$6,56991%
- Education$6399%
Companies that paid Dr. Watson the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Peter Robins Watson graduated from University of North Carolina at Chapel Hill School of Medicine
Dr. Watson graduated from University of North Carolina at Chapel Hill School of Medicine in 1983.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Peter Robins Watson's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Peter Robins Watson
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Peter Robins Watson's NPI number?
Dr. Peter Robins Watson's NPI number is 1376528687. It was assigned on December 8, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Peter Robins Watson?
Dr. Peter Robins Watson is a medical oncologist in Greenville, North Carolina. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Peter Robins Watson practice?
Dr. Watson practices at 2100 Stantonsburg Rd, Greenville, NC 27834. Dr. Watson's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. Dmand AI also links Dr. Watson to 3 medical groups and 2 group practices and clinics.
What is Dr. Peter Robins Watson's office phone number?
The practice phone on file for Dr. Watson is (252) 847-4100.
What is Dr. Peter Robins Watson's medical license number?
Dr. Watson holds North Carolina license 28446.
Which hospitals is Dr. Peter Robins Watson affiliated with?
Dr. Watson practices at ECU Health Medical Center in Greenville, North Carolina.
What medical group is Dr. Peter Robins Watson part of?
Dr. Watson is linked to ECU Health. Dmand AI links Dr. Watson to 3 more medical groups.
Does Dr. Peter Robins Watson accept Medicare?
Yes. CMS data shows Dr. Watson billed Medicare for 146 services in 2024, and Dr. Watson accepts Medicare assignment.
What is Dr. Peter Robins Watson's MIPS score?
Dr. Watson's MIPS final score for performance year 2024 is 97 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Peter Robins Watson see?
CMS counts 51 Medicare patients who saw Dr. Watson in 2024, with an average age of 76.
Show 7 more questionsShow fewer questions
What services does Dr. Peter Robins Watson bill to Medicare?
In 2024, Dr. Watson's most billed Medicare services were quality measure (M0010), office visit, established patient (99214) and lab and pathology test (80053).
Where did Dr. Peter Robins Watson go to medical school?
Dr. Watson graduated from University of North Carolina at Chapel Hill School of Medicine in 1983.
What drugs does Dr. Peter Robins Watson prescribe most?
In 2024 Medicare Part D data, Dr. Watson's most prescribed drugs by claims were Tamoxifen Citrate, Abiraterone Acetate and Anastrozole.
Has Dr. Peter Robins Watson received payments from drug or device companies?
CMS Open Payments shows $7,208 in general payments to Dr. Watson from 54 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Peter Robins Watson been practicing?
Dr. Watson graduated from medical school in 1983, 43 years ago.
Does Dr. Peter Robins Watson do research?
Dmand AI links 3 publications to Dr. Watson, published from 2015 to 2020. Dr. Watson has worked on 10 clinical trials.
Who does Dr. Peter Robins Watson publish with?
Dr. Watson's most frequent co-authors are James Norman Atkins, MD (1 shared paper), Monica Marie Bertagnolli, MD (1 shared paper) and Philip J. Bierman, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card